BiotechTube
Home/Acumen Pharmaceuticals/Paul Shughrue, PhD
PS

Paul Shughrue, PhD

Vice President, Program Leader and Head of Research

Acumen Pharmaceuticals

Therapeutic Areas

Alzheimer's DiseaseNeurodegenerative Diseases

Acumen Pharmaceuticals Pipeline

DrugIndicationPhase
Sabirnetug (ACU193) - Intravenous (IV)Early Alzheimer's DiseasePhase 2
Sabirnetug (ACU193) - Subcutaneous (SC)Early Alzheimer's DiseasePhase 1
Enhanced Brain Delivery (EBD™) PlatformNeurodegenerative DiseasesPreclinical

Leadership Team at Acumen Pharmaceuticals

DO
Daniel O’Connell
Chief Executive Officer
JD
Jim Doherty, PhD
President & Chief Development Officer
ES
Eric Siemers, MD
Chief Medical Officer
MZ
Matthew Zuga
Chief Financial Officer & Chief Business Officer
RB
Russell Barton, MS
Chief Operating Officer
AS
Amy Schacterle, PhD
Chief Regulatory Officer & Head of Quality
DM
Derek Meisner
Chief Legal Officer, Corporate Secretary
JB
Julie Bockenstette
Chief People Officer
View full Acumen Pharmaceuticals profile